Ministry of Science and Technology, 5237 billion won in bio R&D including development of corona treatment and vaccine next year… 25% this year ↑

Input 2020.12.22 12:00

Started’Next year’s bio field original technology development project’

The Ministry of Science and ICT announced on the 22nd that it will invest 5237 billion won for next year’s budget for bio R&D support, such as the development of a new coronavirus infection (Corona 19) treatment and vaccine. This is a 24.9% increase from this year’s original budget (419.3 billion won).

The Ministry of Science and ICT said, “The importance of biotechnology and the necessity of fostering the bio industry as a new industry that will drive the future economy is increasing more than ever due to the recent Corona 19,” and the ‘2021 original technology development project in the bio field’ containing such a plan. He said he would start on.

31.7 billion won will be invested in the development of COVID-19 treatment and vaccine. 10.2 billion won has been newly organized to secure’infectious disease platform technology’ that can quickly cope with the crisis of new and variant infectious diseases that can come after Corona 19.

In preparation for an aging society, KRW 53.3 billion is spent on securing core brain technologies such as brain disease treatment such as dementia and brain-information communication technology (ICT) convergence. 56 billion won will be provided to support the early stages of new drug development, such as finding drug targets (treatment targets) and deriving drug candidates, and to establish an evaluation system for the developed drugs.

A budget of 61.8 billion won was allocated for the medical device business to develop next-generation medical devices based on artificial intelligence (AI) and robots with high market growth potential and to supply them to the disabled and the elderly. 31.1 billion won is spent to support the entire cycle from the development of original technologies in regenerative medicine such as organoids (artificially made mini organs) and dedifferentiated stem cells to clinical trials. 27.1 billion won is also supported to develop new bio materials, biodegradable bioplastics, and bio-innovative products based on natural products.

The announcement of the project to select a researcher will be from the 23rd to the 22nd of the following month.www.msit.go.kr) And the Korea Research Foundation (www.nrf.re.kr) You can check it on the homepage.

Bong-soo Kim, Basic Source Research Policy Officer of the Ministry of Science and ICT, said, “To secure global-level biotechnology competitiveness, we will continue to discover future core technologies, and continue to provide support so that excellent source technologies developed in universities and research centers can be linked to companies and lead to market performance. I will continue.”